These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12419283)
1. Gamma interferon paradoxically inhibits the development of diabetes in the NOD mouse. Sobel DO; Han J; Williams J; Yoon JW; Jun HS; Ahvazi B J Autoimmun; 2002 Nov; 19(3):129-37. PubMed ID: 12419283 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse. Stephens LA; Kay TW Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558 [TBL] [Abstract][Full Text] [Related]
3. Alpha-interferon inhibits the development of diabetes in NOD mice. Sobel DO; Ahvazi B Diabetes; 1998 Dec; 47(12):1867-72. PubMed ID: 9836517 [TBL] [Abstract][Full Text] [Related]
4. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. Hussain S; Delovitch TL J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886 [TBL] [Abstract][Full Text] [Related]
5. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction. Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970 [TBL] [Abstract][Full Text] [Related]
6. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375 [TBL] [Abstract][Full Text] [Related]
7. The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse. Sobel DO; Yankelevich B; Goyal D; Nelson D; Mazumder A Diabetes; 1998 Feb; 47(2):186-91. PubMed ID: 9519711 [TBL] [Abstract][Full Text] [Related]
8. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells. Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326 [TBL] [Abstract][Full Text] [Related]
9. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells. Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884 [TBL] [Abstract][Full Text] [Related]
10. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice. Rivereau AS; You S; Lalain S; Gouin E; Saï P Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345 [TBL] [Abstract][Full Text] [Related]
11. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337 [TBL] [Abstract][Full Text] [Related]
12. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Chosich N; Harrison LC Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738 [TBL] [Abstract][Full Text] [Related]
13. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426 [TBL] [Abstract][Full Text] [Related]
14. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas. Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924 [TBL] [Abstract][Full Text] [Related]
15. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. Han HS; Jun HS; Utsugi T; Yoon JW J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968 [TBL] [Abstract][Full Text] [Related]
16. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Tominaga Y; Nagata M; Yasuda H; Okamoto N; Arisawa K; Moriyama H; Miki M; Yokono K; Kasuga M Clin Immunol Immunopathol; 1998 Feb; 86(2):209-18. PubMed ID: 9473384 [TBL] [Abstract][Full Text] [Related]
17. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes. Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642 [TBL] [Abstract][Full Text] [Related]
18. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice. Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727 [TBL] [Abstract][Full Text] [Related]
19. Interferon-tau inhibits the development of diabetes in NOD mice. Sobel DO; Ahvazi B; Amjad F; Mitnaul L; Pontzer C Autoimmunity; 2008 Nov; 41(7):543-53. PubMed ID: 18608174 [TBL] [Abstract][Full Text] [Related]
20. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes. Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]